Abstract:The classic concept of the absence of lymphatic vessels in the central nervous system (CNS), suggesting the immune privilege of the brain in spite of its high metabolic rate, was predominant until recent times. On the other hand, this idea left questioned how cerebral interstitial fluid is cleared of waste products. It was generally thought that clearance depends on cerebrospinal fluid (CSF). Not long ago, an anatomically and functionally discrete paravascular space was revised to provide a pathway for the clearance of molecules drained within the interstitial space. According to this model, CSF enters the brain parenchyma along arterial paravascular spaces. Once mixed with interstitial fluid and solutes in a process mediated by aquaporin-4, CSF exits through the extracellular space along venous paravascular spaces, thus being removed from the brain. This process includes the participation of perivascular glial cells due to a sieving effect of their end-feet. Such draining space resembles the peripheral lymphatic system, therefore, the term "glymphatic" (glial-lymphatic) pathway has been coined. Specific studies focused on the potential role of the glymphatic pathway in healthy and pathological conditions, including neurodegenerative diseases. This mainly concerns Alzheimer's disease (AD), as well as hemorrhagic and ischemic neurovascular disorders; other acute degenerative processes, such as normal pressure hydrocephalus or traumatic brain injury are involved as well. Novel morphological and functional investigations also suggested alternative models to drain molecules through perivascular pathways, which enriched our insight of homeostatic processes within neural microenvironment. Under the light of these considerations, the present article aims to discuss recent findings and concepts on nervous lymphatic drainage and blood-brain barrier (BBB) in an attempt to understand how peripheral pathological conditions may be detrimental to the CNS, paving the way to neurodegeneration.

The meningeal lymphatic vessels and the glymphatic system: Potential therapeutic targets in neurological disorders

The meningeal lymphatic vessels and the glymphatic system: Potential therapeutic targets in neurological disorders

Impaired Meningeal Lymphatics and Glymphatic Pathway in Patients with White Matter Hyperintensity

Glymphatic system: an emerging therapeutic approach for neurological disorders

Impairment of glymphatic pathway and putative meningeal lymphatic vessels in aging human.

Lymphatic drainage system of the brain: A novel target for intervention of neurological diseases

The lymphatic system: a therapeutic target for central nervous system disorders

Meningeal lymphatics and their role in CNS disorder treatment: moving past misconceptions

Progress on Brain and Ocular Lymphatic System

The glymphatic system and meningeal lymphatics of the brain: new understanding of brain clearance

Advances in Research on Meningeal Lymphatic Vessels in Central Nervous System Diseases

Exploring neurodegenerative disorders using advanced magnetic resonance imaging of the glymphatic system

Meningeal Lymphatics in Central Nervous System Diseases

Modulation of lymphatic transport in the central nervous system

The glymphatic system: implications for drugs for central nervous system diseases

Glymphatic System as a Gateway to Connect Neurodegeneration From Periphery to CNS

Overview of the meningeal lymphatic vessels in aging and central nervous system disorders

The Underlying Role of the Glymphatic System and Meningeal Lymphatic Vessels in Cerebral Small Vessel Disease

Enlarged Perivascular Space and Index for Diffusivity Along the Perivascular Space as Emerging Neuroimaging Biomarkers of Neurological Diseases

Glymphatic-lymphatic coupling: assessment of the evidence from magnetic resonance imaging of humans